1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma

Plenary Session

English - July 05, 2019 18:01 - 2 hours - 118 MB - ★★★★★ - 732 ratings
Science Health & Fitness Medicine medicine oncology health policy Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: 1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina

Next Episode: 2.01 Selinexor, ECHELON-2, Parachutes, Tumor-Treating Fields, & MedTwitter

We begin this week's episode by breaking down the recent phase III trial on voxeletor in sickle cell disease with Dr. Sven Olson of OHSU. Next, we feature guest Dr. David Steensma of the Dana-Farber Cancer Institute in a far-reaching interview on being well-read, running a small lab, humanizing cancer, learning from our past use of erythropoiesis-stimulating agents, understanding the headache of contract research organizations, defining cancer, and more!

Voxeletor in Sickle Cell: doi.org/10.1056/NEJMoa1903212
Don't Mention It: doi.org/10.1200/JCO.2008.17.7238
The Raven: doi.org/10.1200/JCO.2017.76.3458
Erythropoietin Use in Cancer: doi.org/10.1200/JCO.2005.05.036
Contract Research Organizations: doi.org/10.1002/cncr.29994

Back us on Patreon! www.patreon.com/plenarysession